Corneal endothelial deposits secondary to rifabutin prophylaxis for Mycobacterium avium complex bacteraemia [10]

British Journal of Ophthalmology

Volumn 87, Issue 6, 2003, Pages 798-799

  Golchin, B ^a   McClellan, Kathleen ^a  

^a SYDNEY EYE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

RIFABUTIN;

ADULT; ANTIBIOTIC PROPHYLAXIS; BACTEREMIA; CASE REPORT; CLINICAL FEATURE; CORNEA DISEASE; CORNEA ENDOTHELIUM; CORNEAL ENDOTHELIAL DEPOSIT; DNA SYNTHESIS INHIBITION; HUMAN; LETTER; MALE; MYCOBACTERIOSIS; MYCOBACTERIUM AVIUM; NONHUMAN; PRIORITY JOURNAL; SIDE EFFECT; UVEITIS;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIBIOTICS, ANTITUBERCULAR; BACTEREMIA; CORNEAL DISEASES; ENDOTHELIUM, CORNEAL; HUMANS; MALE; MIDDLE AGED; MYCOBACTERIUM AVIUM COMPLEX; MYCOBACTERIUM AVIUM-INTRACELLULARE INFECTION; RIFABUTIN;

EID: 0037680294     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.87.6.798     Document Type: Letter

References (6)

1. Nightingale SD, Camerson DW, Gordon FM, et al. Two controlled trials of rifabutin prophylaxis against Mycobacterium avium complex infection in AIDS. N Engl J Med 1993;329:828-33.
2. Physicians' Desk Reference. Montvale, NJ: Medical Economics, 1995:1893-5.
3. Jacobs DS, Piliero PJ, Kuperwaser MG, et al. Acute uveitis associated with rifabutin use in patients with human immunodeficiency virus infection. Am J Ophthalmol 1994;118:716-22.
4. Saran BR, Maguire AM, Nichols C, et al. Hypopyon uveitis in patients with acquired immunodeficiency syndrome treated for systemic Mycobacterium avium complex infection with rifabutin. Arch Ophthalmol 1994;112:1159-65.
5. Skinner MH, Blaschke TF. Clinical pharmacokinetics of rifabutin. Clin Pharmacokinet 1995;28:115-23.
6. Smith JA, Muller BU, Nussenblatt RB, et al. Corneal endothelial deposits in children positive for human immunodeficiency virus receiving rifabutin prophylaxis for Mycobacterium avium complex bacteremia. Am J Ophthalmol 1999;127:164-9.